Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drugs
Metadata
Title
The Role of COX-2 Inhibitors in Pain Modulation
Authors
Professor Frederic Camu
Lin Shi
Caroline Vanlersberghe
Publication date
01-11-2003
Publisher
Springer International Publishing
Published in
Drugs / Issue Special Issue 1/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200363001-00002

Other articles of this Special Issue 1/2003

Drugs 1/2003 Go to the issue

EditorialNotes

Foreword

Original Research Article

A Randomised, Double-Blind, Clinical Trial Comparing the Efficacy of Nimesulide, Celecoxib and Rofecoxib in Osteoarthritis of the Knee

Original Research Article

Inhibition of PGE2 Production by Nimesulide Compared with Diclofenac in the Acutely Inflamed Joint of Patients with Arthritis

Original Research Article

Central Components of the Analgesic/ Antihyperalgesic Effect of Nimesulide: Studies in Animal Models of Pain and Hyperalgesia

Original Research Article

High-throughput Proteomics and Protein Biomarker Discovery in an Experimental Model of Inflammatory Hyperalgesia: Effects of Nimesulide